Farallon Capital Management, L.l.c.

San Francisco, CA 87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

$21.7B
77 holdings
2026 Q2
+23.6% QoQ
Top 5 29.9%

Portfolio

2026 Q2, filed 8/14/2026, top 12 of 77 holdings

Top 5 29.9%, top 10 44.0%

AUM over time

2026 Q2 $21.7B +23.6% QoQ

Q3 2021

Q1 2022

Q1 2023

Q1 2024

Q1 2025

Q1 2026

Book

2024 Q1 2023 Q4, filed 15 May, long equity only

Download CSV Download Excel All activity


Pioneer Natural Resources	4.18%	New	3,520,000	$262.50	$924M	+3,520,000	+$924M
UNH, UnitedHealth Group	3.81%, was 3.14%	Add +41.5%	1,701,410	$494.70	$842M	+498,810	+$209M
IQV, IQVIA	3.24%, was 3.40%	Reduce −4.2%	2,836,162	$252.89	$717M	−124,870	+$32M
EXEL, Exelixis	2.86%	Add +0.2%	26,678,500	$23.73	$633M	+44,000	−$5.9M
CRM, Salesforce	2.66%, was 2.52%	Add +1.4%	1,952,168	$301.18	$588M	+26,430	+$81M
ARMK, Aramark	2.62%, was 2.36%	Add +5.5%	17,822,937	$32.52	$580M	+923,683	+$105M
NDAQ, Nasdaq	2.41%, was 1.90%	Add +28.4%	8,436,719	$63.10	$532M	+1,866,219	+$150M
MSFT, Microsoft	2.30%, was 2.50%	Reduce −9.5%	1,211,458	$420.72	$510M	−127,120	+$6.3M
GOOG, Alphabet	2.30%, was 2.20%	Add +6.4%	3,337,950	$152.26	$508M	+199,410	+$66M
TRU, Transunion	2.29%, was 3.11%	Reduce −30.4%	6,351,256	$79.80	$507M	−2,771,700	−$120M
NYT, New York Times	2.19%	Add +18.1%	11,188,059	$43.22	$484M	+1,711,268	+$19M
TMO, Thermo Fisher Scientific	2.10%, was 3.17%	Reduce −33.7%	797,416	$581.21	$463M	−405,715	−$175M
WAB, Wabtec	1.95%, was 2.48%	Reduce −24.9%	2,956,398	$145.68	$431M	−981,910	−$69M
CBRE, CBRE Group	1.84%, was 1.96%	Reduce −1.5%	4,184,030	$97.24	$407M	−61,970	+$12M
NTRA, Natera	1.62%, was 1.08%	Add +13.0%	3,927,683	$91.46	$359M	+452,800	+$142M
INTU, Intuit	1.58%	Add +0.8%	537,078	$650.00	$349M	+4,078	+$16M
SPGI, S&P Global	1.53%, was 1.93%	Reduce −10.1%	793,844	$425.45	$338M	−88,751	−$51M
Sarepta Therapeutics	1.44%, was 0.58%	Add +102.8%	2,453,500	$129.46	$318M	+1,243,427	+$201M
BSX, Boston Scientific	1.42%, was 1.67%	Reduce −21.0%	4,596,657	$68.49	$315M	−1,223,600	−$22M
ADI, Analog Devices	1.38%	Add +3.3%	1,537,990	$197.79	$304M	+48,890	+$8.5M
NOW, ServiceNow	1.36%, was 1.48%	Reduce −6.2%	395,088	$762.40	$301M	−26,162	+$3.6M
ABNB, Airbnb	1.20%	New	1,608,220	$164.96	$265M	+1,608,220	+$265M
SHW, Sherwin-Williams	1.18%, was 1.29%	Reduce −9.4%	753,830	$347.33	$262M	−78,262	+$2.3M
CSGP, CoStar Group	1.13%, was 1.35%	Reduce −16.9%	2,594,356	$96.60	$251M	−527,000	−$22M
MA, Mastercard	1.12%, was 1.31%	Reduce −17.2%	513,161	$481.57	$247M	−106,310	−$17M
RVMD, Revolution Medicines	1.09%, was 0.96%	Add +11.4%	7,507,872	$32.23	$242M	+771,018	+$49M
HWM, Howmet Aerospace	1.06%, was 1.27%	Reduce −27.7%	3,410,759	$68.43	$233M	−1,305,268	−$22M
Masimo	0.99%, was 0.76%	Add +13.6%	1,489,563	$146.85	$219M	+177,914	+$65M
AON, Aon	0.95%	New	632,000	$333.72	$211M	+632,000	+$211M
CNC, Centene	0.93%, was 1.52%	Reduce −36.9%	2,607,875	$78.48	$205M	−1,524,200	−$102M
YMM, Full Truck Alliance	0.86%, was 1.33%	Reduce −31.2%	26,285,059	$7.27	$191M	−11,905,436	−$77M
V, Visa	0.86%, was 1.03%	Reduce −14.7%	680,850	$279.08	$190M	−117,260	−$18M
PTGX, Protagonist Therapeutics	0.75%, was 0.65%	Add +0.1%	5,738,973	$28.93	$166M	+4,543	+$35M
AGIO, Agios Pharmaceuticals	0.74%, was 0.46%	Add +34.1%	5,590,602	$29.24	$163M	+1,423,000	+$71M
BEAM, Beam Therapeutics	0.67%, was 0.55%	Add +9.9%	4,511,753	$33.04	$149M	+406,000	+$37M
INSP, Inspire Medical Systems	0.61%, was 0.86%	Reduce −26.7%	626,854	$214.79	$135M	−228,242	−$39M
Holding	0.57%, was 0.05%	Add +271.1%	5,790,500	$21.60	$125M	+4,230,000	+$116M
AZNN	0.45%, was 1.28%	Reduce −61.8%	1,459,718	$67.75	$99M	−2,364,573	−$159M
VSTS, Vestis	0.43%, was 0.57%	Reduce −10.1%	4,914,753	$19.27	$95M	−555,000	−$21M
LNTH, Lantheus	0.42%, was 0.07%	Add +595.3%	1,483,227	$62.24	$92M	+1,269,900	+$79M
GBTC, Grayscale Bitcoin Trust BTC	0.39%	New	1,349,077	$63.17	$85M	+1,349,077	+$85M
COR, Cencora	0.37%, was 0.17%	Add +97.6%	334,000	$242.99	$81M	+165,000	+$46M
THC, Tenet Healthcare	0.30%, was 0.14%	Add +70.1%	637,442	$105.11	$67M	+262,600	+$39M
SIMO, Silicon Motion Technology	0.30%, was 0.07%	Add +247.0%	855,449	$76.94	$66M	+608,949	+$51M
BEKE, KE Holdings	0.29%, was 0.38%	Reduce −0.4%	4,740,833	$13.73	$65M	−17,667	−$12M
ICLR, Icon	0.27%	New	179,700	$335.95	$60M	+179,700	+$60M
EDU	0.24%	Add +4630.8%	615,000	$86.82	$53M	+602,000	+$52M
BHVN, Biohaven	0.20%, was 0.16%	Add +6.5%	799,000	$54.69	$44M	+49,000	+$12M
ENTA, Enanta Pharmaceuticals	0.17%, was 0.09%	Add +3.5%	2,095,000	$17.46	$37M	+70,000	+$18M
EVH, Evolent Health	0.15%, was 0.35%	Reduce −52.1%	1,037,331	$32.79	$34M	−1,126,578	−$37M
IONS, Ionis Pharmaceuticals	0.14%, was 0.39%	Reduce −52.8%	734,000	$43.35	$32M	−821,020	−$47M
LQDA, Liquidia	0.14%	New	2,055,000	$14.75	$30M	+2,055,000	+$30M
HIMS, Hims & Hers Health	0.12%	Add +3890.5%	1,676,000	$15.47	$26M	+1,634,000	+$26M
PCVX, Vaxcyte	0.12%	Add +11000.0%	377,400	$68.31	$26M	+374,000	+$26M
UTHR, United Therapeutics	0.11%, was 0.52%	Reduce −76.9%	110,000	$229.72	$25M	−366,000	−$79M
GERN, Geron	0.11%	New	7,495,000	$3.30	$25M	+7,495,000	+$25M
BABA, Alibaba	0.11%, was 0.21%	Reduce −38.5%	329,000	$72.36	$24M	−206,000	−$18M
PGNY, Progyny	0.10%	New	592,600	$38.15	$23M	+592,600	+$23M
VYGR, Voyager Therapeutics	0.10%, was 0.05%	Add +77.4%	2,292,000	$9.31	$21M	+1,000,000	+$10M
PCG, PG&E	0.10%, was 0.20%	Reduce −44.0%	1,271,642	$16.76	$21M	−1,000,000	−$20M
APGE, Apogee Therapeutics	0.09%	New	305,000	$66.45	$20M	+305,000	+$20M
Elevation Oncology	0.09%	New	3,886,663	$5.13	$20M	+3,886,663	+$20M
HUM, Humana	0.08%, was 0.28%	Reduce −57.4%	51,700	$346.72	$18M	−69,644	−$38M
SYRE, Spyre Therapeutics	0.08%	New	466,000	$37.93	$18M	+466,000	+$18M
ARQT, Arcutis Biotherapeutics	0.08%	New	1,780,000	$9.91	$18M	+1,780,000	+$18M
Ventyx Biosciences	0.08%	New	3,170,000	$5.50	$17M	+3,170,000	+$17M
Zymeworks	0.08%, was 0.09%	Reduce −8.8%	1,601,000	$10.52	$17M	−155,000	−$1.4M
ASND, Ascendis Pharma A/s	0.07%	New	109,000	$151.17	$16M	+109,000	+$16M
Intra-Cellular Therapies	0.07%	New	231,000	$69.20	$16M	+231,000	+$16M
TAL, Tal Education Group	0.07%	Hold	1,365,000	$11.35	$15M	—	—
RNA, Avidity Biosciences	0.07%	New	606,061	$25.52	$15M	+606,061	+$15M
Immunome	0.07%	New	594,000	$24.68	$15M	+594,000	+$15M
Metagenomi	0.06%	New	1,343,201	$10.55	$14M	+1,343,201	+$14M
PACB	0.06%, was 0.30%	Reduce −39.1%	3,772,452	$3.75	$14M	−2,418,918	−$47M
Savara	0.05%, was 0.15%	Reduce −61.7%	2,394,299	$4.98	$12M	−3,861,107	−$17M
QTRX, Quanterix	0.05%, was 0.02%	Add +156.0%	471,000	$23.56	$11M	+287,000	+$6.1M
Screaming Eagle Acquisitn	0.05%	Hold	1,000,000	$10.70	$11M	—	—
ROIV, Roivant Sciences	0.04%, was 0.41%	Reduce −87.8%	898,600	$10.54	$9.5M	−6,437,400	−$73M
RIO, Rio Tinto	0.04%	Hold	137,500	$63.74	$8.8M	—	—
Cazoo Group	0.04%	Hold	714,240	$12.00	$8.6M	—	—
BRKR, Bruker	0.04%	Add +2670.0%	83,100	$93.94	$7.8M	+80,100	+$7.6M
Gossamer Bio	0.03%	Hold	6,130,272	$1.18	$7.2M	—	—
CYTK, Cytokinetics	0.03%, was 0.45%	Reduce −90.6%	102,400	$70.11	$7.2M	−985,372	−$84M
Helix Acquisition Corporation II	0.03%	New	600,000	$10.35	$6.2M	+600,000	+$6.2M
NVAX, Novavax	0.02%	New	1,131,000	$4.78	$5.4M	+1,131,000	+$5.4M
PRME, Prime Medicine	0.02%	New	750,000	$7.00	$5.3M	+750,000	+$5.3M
ALT, Altimmune	0.02%	Add +1282.4%	470,000	$10.18	$4.8M	+436,000	+$4.4M
GDS, GDS Holdings	0.02%	New	710,000	$6.65	$4.7M	+710,000	+$4.7M
RARE	0.02%	New	99,000	$46.69	$4.6M	+99,000	+$4.6M
CNTA, Centessa Pharmaceuticals	0.02%	New	371,000	$11.30	$4.2M	+371,000	+$4.2M
AMLX, Amylyx Pharmaceuticals	0.01%	New	1,150,221	$2.84	$3.3M	+1,150,221	+$3.3M
Swiftmerge Acquisition	0.01%	Hold	300,000	$10.82	$3.2M	—	—
COGT, Cogent Biosciences	0.01%	Add +2617.6%	462,000	$6.72	$3.1M	+445,000	+$3M
PRAX	0.01%	New	50,000	$61.02	$3.1M	+50,000	+$3.1M
Berenson Acquisition	0.01%	Hold	285,715	$10.35	$3M	—	—
AVBP, Arrivent Biopharma	0.01%	New	151,768	$17.86	$2.7M	+151,768	+$2.7M
Arya Sciences Acqu Corporation IV	0.01%	Hold	200,000	$11.27	$2.3M	—	—
Metals Acquisition	0.01%	Hold	157,500	$12.85	$2M	—	—
Summit Midstream Partners	0.01%	Hold	58,214	$28.07	$1.6M	—	—
Marblegate Acquisition	0.01%	Hold	150,000	$10.46	$1.6M	—	—
Cara Therapeutics	0.01%	Hold	1,556,251	$0.9100	$1.4M	—	—
Forte Biosciences	0.01%	Hold	1,810,455	$0.7007	$1.3M	—	—
SLNO, Soleno Therapeutics	0.01%, was 0.03%	Reduce −83.2%	27,750	$42.80	$1.2M	−137,469	−$5.5M
VNET, Vnet Group	0.00%, was 0.03%	Reduce −63.4%	650,000	$1.55	$1M	−1,125,000	−$4.1M
MDGL, Madrigal Pharmaceuticals	0.00%	Hold	3,319	$267.04	$886K	—	—
Sage Therapeutics	0.00%	Hold	42,800	$18.74	$802K	—	—
Lufax	0.00%	Hold	149,999	$4.22	$633K	—	—
IOVA, Iovance Biotherapeutics	0.00%, was 0.02%	Reduce −95.4%	26,000	$14.82	$385K	−536,000	−$4.2M
Blueprint Medicines	0.00%	Hold	4,000	$94.86	$379K	—	—
KRYS, Krystal Biotech	0.00%	Hold	2,000	$177.93	$356K	—	—
APLS, Apellis Pharmaceuticals	0.00%	Hold	6,000	$58.78	$353K	—	—
HCA, HCA Healthcare	0.00%, was 0.03%	Reduce −95.2%	1,000	$333.53	$334K	−19,900	−$5.3M
AXSM, Axsome Therapeutics	0.00%	Hold	4,000	$79.80	$319K	—	—
ALNY, Alnylam Pharmaceuticals	0.00%	Hold	2,000	$149.45	$299K	—	—
ACLX, Arcellx	0.00%	Hold	4,000	$69.55	$278K	—	—
CHE, Chemed	0.00%	Hold	400	$641.93	$257K	—	—
EHC, Encompass Health	0.00%	Hold	3,000	$82.58	$248K	—	—
GKOS, Glaukos	0.00%	Hold	2,600	$94.29	$245K	—	—
SNDX, Syndax Pharmaceuticals	0.00%	Hold	10,000	$23.80	$238K	—	—
CRNX	0.00%, was 0.02%	Reduce −95.9%	5,000	$46.81	$234K	−117,904	−$4.1M
ACHC	0.00%	Hold	2,800	$79.22	$222K	—	—
SBRA, Sabra Health Care REIT	0.00%	Hold	14,000	$14.77	$207K	—	—
R1 RCM	0.00%	Hold	16,000	$12.88	$206K	—	—
FOLD, Amicus	0.00%	Hold	16,000	$11.78	$188K	—	—

Showing top 50 of 124 by value

Exits / last held

Gone since 2023 Q4, shown at their last reported size.

Stock	% of portfolio	Recent activity	Reported price*	Value	Share change	$ change
CHTR, Charter Communications	1.54%	Exit	$388.68	$311M	−799,141	−$311M
BX, Blackstone	1.10%	Exit	$130.92	$222M	−1,697,351	−$222M
Mirati Therapeutics	0.59%	Exit	$58.75	$119M	−2,024,472	−$119M
Catalent	0.32%	Exit	$44.93	$63M	−1,413,000	−$63M
Immunogen	0.12%	Exit	$29.65	$25M	−842,000	−$25M
Holding	0.12%	Exit	$42.40	$24M	−567,321	−$24M
VRTX, Vertex Pharmaceuticals	0.11%	Exit	$406.89	$22M	−55,000	−$22M
OPCH, Option Care Health	0.09%	Exit	$33.69	$19M	−567,800	−$19M
IMVT, Immunovant	0.07%	Exit	$42.13	$14M	−341,000	−$14M
TVTX, Travere Therapeutics	0.05%	Exit	$8.99	$9.8M	−1,094,000	−$9.8M
NBIX, Neurocrine Biosciences	0.05%	Exit	$131.76	$9.5M	−72,398	−$9.5M
Gores Holdings IX	0.03%	Exit	$10.50	$5.3M	−500,000	−$5.3M
Bluebird Bio	0.01%	Exit	$1.38	$2.8M	−2,000,000	−$2.8M
CRL, Charles River Labs International	—	Exit	$236.50	$473K	−2,000	−$473K
BNTX, Biontech	—	Exit	$105.62	$406K	−3,844	−$406K
BBIO, Bridgebio	—	Exit	$40.33	$242K	−6,000	−$242K
MLTX, Moonlake Immunotherapeutics	—	Exit	$60.29	$205K	−3,400	−$205K
IART	—	Exit	$43.48	$200K	−4,600	−$200K

Filings history

20 periods, with AUM normalized

Newest 13Fs

Period	Holds	AUM	QoQ	Form	Filed	Filing ID
2026 Q2	89	$21.7B	+23.6%	13F-HR	8/14/2026	000090883426000432
2026 Q1	1	$1.5B	—	new holds	8/14/2026	000090883426000434
2026 Q1	172	$17.5B	−17.2%	13F-HR	5/15/2026	000090883426000240
2025 Q4	1	$1B	—	new holds	8/14/2026	000090883426000433
2025 Q4	2	$884M	—	new holds	5/15/2026	000090883426000241
2025 Q4	151	$21.2B	−13.2%	13F-HR	2/17/2026	000090883426000087
2025 Q3	144	$24.4B	—	RESTATEMENT	2/17/2026	000090883426000086
2025 Q3	144	$24.4B	+5.4%	13F-HR	11/14/2025	000090883425000353
2025 Q2	1	$140M	—	new holds	2/17/2026	000090883426000085
2025 Q2	3	$483M	—	new holds	11/14/2025	000090883425000352
2025 Q2	141	$23.2B	+29.2%	13F-HR	8/14/2025	000090883425000248
2025 Q1	1	$274M	—	new holds	2/17/2026	000090883426000084
2025 Q1	3	$416M	—	new holds	11/14/2025	000090883425000351
2025 Q1	7	$2.2B	—	new holds	8/14/2025	000090883425000247
2025 Q1	135	$17.9B	−9.0%	13F-HR	5/15/2025	000090883425000177
2024 Q4	1	$85M	—	new holds	2/17/2026	000090883426000083
2024 Q4	2	$349M	—	new holds	11/14/2025	000090883425000350
2024 Q4	6	$2.3B	—	new holds	8/14/2025	000090883425000246
2024 Q4	4	$333M	—	new holds	5/15/2025	000090883425000180
2024 Q4	138	$19.7B	−3.5%	13F-HR	2/14/2025	000090883425000081
2024 Q3	1	$145M	—	new holds	11/14/2025	000090883425000349
2024 Q3	6	$1.5B	—	new holds	8/14/2025	000090883425000243
2024 Q3	3	$216M	—	new holds	5/15/2025	000090883425000179
2024 Q3	2	$544M	—	new holds	2/14/2025	000090883425000080
2024 Q3	153	$20.4B	−3.6%	13F-HR	11/14/2024	000090883424000307
2024 Q2	1	$120M	—	new holds	11/14/2025	000090883425000348
2024 Q2	5	$1.2B	—	new holds	8/14/2025	000090883425000245
2024 Q2	1	$199M	—	new holds	5/15/2025	000090883425000178
2024 Q2	2	$452M	—	new holds	2/14/2025	000090883425000079
2024 Q2	1	$149M	—	new holds	11/14/2024	000090883424000324
2024 Q2	157	$21.2B	−4.2%	13F-HR	8/14/2024	000090883424000200
2024 Q1	1	$93M	—	new holds	11/14/2025	000090883425000347
2024 Q1	4	$1.2B	—	new holds	8/14/2025	000090883425000244
2024 Q1	2	$159M	—	new holds	2/14/2025	000090883425000078
2024 Q1	1	$45M	—	new holds	8/14/2024	000090883424000202
2024 Q1	167	$22.1B	—	RESTATEMENT	5/24/2024	000090883424000159
2024 Q1	167	$22.1B	+9.8%	13F-HR	5/15/2024	000090883424000135
2023 Q4	1	$65M	—	new holds	11/14/2025	000090883425000346
2023 Q4	2	$548M	—	new holds	8/14/2025	000090883425000250
2023 Q4	5	$1.1B	—	new holds	5/15/2024	000090883424000141
2023 Q4	150	$20.1B	+1.0%	13F-HR	2/14/2024	000090883424000070
2023 Q3	1	$40M	—	new holds	11/14/2025	000090883425000345
2023 Q3	1	$40M	—	new holds	5/15/2024	000090883424000138
2023 Q3	2	$1.4B	—	new holds	2/14/2024	000090883424000077
2023 Q3	1	$1.9B	—	new holds	2/12/2024	000090883424000049
2023 Q3	159	$20B	+11.5%	13F-HR	11/14/2023	000090883423000150
2023 Q2	2	$669M	—	new holds	2/14/2024	000090883424000076
2023 Q2	5	$1.4B	—	new holds	11/14/2023	000090883423000157
2023 Q2	1	$1.2B	—	new holds	10/26/2023	000090883423000134
2023 Q2	165	$17.9B	+1.3%	13F-HR	8/14/2023	000090883423000109
2023 Q1	2	$234M	—	new holds	2/14/2024	000090883424000075
2023 Q1	3	$389M	—	new holds	11/14/2023	000090883423000156
2023 Q1	1	$15M	—	new holds	8/14/2023	000090883423000110
2023 Q1	187	$17.7B	+15.8%	13F-HR	5/15/2023	000117570723000127
2022 Q4	1	$171M	—	new holds	2/14/2024	000090883424000074
2022 Q4	3	$485M	—	new holds	11/14/2023	000090883423000155
2022 Q4	7	$1B	—	new holds	5/15/2023	000117570723000136
2022 Q4	232	$15.3B	−9.3%	13F-HR	2/14/2023	000117570723000051
2022 Q3	1	$125M	—	new holds	2/14/2024	000090883424000073
2022 Q3	3	$415M	—	new holds	11/14/2023	000090883423000154
2022 Q3	5	$411M	—	new holds	5/15/2023	000117570723000135
2022 Q3	4	$434M	—	new holds	2/14/2023	000090966123000005
2022 Q3	298	$16.8B	+3.5%	13F-HR	11/14/2022	000156761922019851
2022 Q2	1	$115M	—	new holds	2/14/2024	000090883424000081
2022 Q2	3	$411M	—	new holds	11/14/2023	000090883423000153
2022 Q2	2	$337M	—	new holds	5/15/2023	000117570723000134
2022 Q2	3	$136M	—	new holds	2/14/2023	000090966123000003
2022 Q2	9	$1.2B	—	new holds	11/14/2022	000156761922019862
2022 Q2	297	$16.3B	−13.7%	13F-HR	8/15/2022	000156761922015953
2022 Q1	1	$268M	—	new holds	11/14/2023	000090883423000152
2022 Q1	1	$314M	—	new holds	5/15/2023	000117570723000133
2022 Q1	1	$27M	—	new holds	2/14/2023	000090966123000002
2022 Q1	3	$186M	—	new holds	11/14/2022	000156761922019864
2022 Q1	8	$1.1B	—	new holds	8/15/2022	000156761922015972
2022 Q1	307	$18.8B	+0.4%	13F-HR	5/16/2022	000156761922010736
2021 Q4	1	$227M	—	new holds	5/15/2023	000117570723000132
2021 Q4	1	$7M	—	new holds	11/14/2022	000156761922019852
2021 Q4	1	$115M	—	new holds	8/15/2022	000156761922015968
2021 Q4	2	$98M	—	new holds	5/19/2022	000156761922011257
2021 Q4	6	$833M	—	new holds	5/16/2022	000156761922010757
2021 Q4	289	$18.7B	−5.1%	13F-HR	2/14/2022	000156761922003965
2021 Q3	1	$182M	—	new holds	5/15/2023	000117570723000131
2021 Q3	1	$105M	—	new holds	8/15/2022	000156761922015964
2021 Q3	1	$57M	—	new holds	5/19/2022	000156761922011256
2021 Q3	3	$998M	—	new holds	5/16/2022	000156761922010753
2021 Q3	2	$344M	—	new holds	2/14/2022	000156761922003981
2021 Q3	293	$19.7B	—	13F-HR	11/15/2021	000095012321015168

About

Farallon Capital Management, L.l.c.

87 processed 13Fs on this site, 2021 Q3 to 2026 Q2

SEC filing name: FARALLON CAPITAL MANAGEMENT, L.L.C.
Location: San Francisco, CA
All SEC filings: View on sec.gov